Zacks Investment Research
13 Nov 2026, 17:45 UTC · 34m ago
Impact · against what's priced in
The strong fiscal Q1 2027 growth for Viavi is offset by significant share dilution and a recent correction after a 92% annual run. While fundamentals are accelerating, the recent price pullback suggests the market is recalibrating the valuation of this growth.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Viavi's fiscal first-quarter 2027 revenues rose 56.9% year over year to $469.3 million.
Priced inanalysis of fiscal Q1 results
So whatNon-GAAP EPS growth of 213% (15c to 47c) suggests significant operating leverage on this revenue beat.
More positive than 93% of claims this week
Management expects the semiconductor-test opportunity to exceed $100 million in annual revenues within a few years.
Continue reading
5 related stories
Fiscal first-quarter revenues rose 56.9% to $469.3 million and non-GAAP EPS jumped to 47 cents from 15 cents, though a 19.4% increase in share count partially offsets these gains.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inanalysis of results/guidance
So whatThis new revenue stream represents roughly 21% of current quarterly revenue if scaled to an annualized basis.
More positive than 77% of claims this week
The diluted share count increased to 266.2 million from 222.9 million a year earlier.
Priced inanalysis of fiscal Q1 results
So whatThe 19.4% increase in shares dilutes the impact of earnings growth on a per-share basis for FY2027.
More negative than 75% of claims this week
Viavi shares have fallen 11.6% over the past month.
Priced indescription of past month price action
So whatThe stock remains up 80.6% over the past year despite the recent pullback.
More negative than 68% of claims this week
Which stocks this story touches
More positive than 55% of ticker scores this week
Strong fiscal first-quarter growth in revenues and earnings despite a recent stock price pullback.
More positive than 48% of ticker scores this week
Mentioned as benefiting from broad demand across advanced testing markets for AI and semiconductor customers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
29m ago
−5.6%
Price is moving against the score
$30.71 vs $32.54 close before publication (Nov 12) · not market-adjusted
VIAV chart →
